BACKGROUND: Observational and experimental studies suggest that vitamin D may influence breast cancer etiology. Most known effects of vitamin D are mediated via the vitamin D receptor (VDR). Few polymorphisms in the VDR gene have been well studied in relation to breast cancer risk and results have been inconsistent. METHODS: We investigated VDR polymorphisms and haplotypes in relation to breast cancer risk by genotyping 26 single nucleotide polymorphisms (SNP) that (i) had known/suspected impact on VDR function, (ii) were tagging SNPs for the three VDR haplotype blocks among whites, or (iii) were previously associated with breast cancer risk. We estimated odds ratios (OR) and 95% confidence intervals (CI) in relation to breast cancer risk among 270 incident cases and 554 matched controls within the Agricultural Health Study cohort. RESULTS: In individual SNP analyses, homozygous carriers of the minor allele for rs2544038 had significantly increased breast cancer risk (OR = 1.5; 95% CI: 1.0-2.5) and homozygous carriers of the minor allele for rs11168287 had significantly decreased risk (OR = 0.6; 95% CI: 0.4-1.0). Carriers of the minor allele for rs2239181 exhibited marginally significant association with risk (OR = 1.4; 95% CI: 0.9-2.0). Haplotype analyses revealed three haplotype groups (blocks "A," "B," and "C"). Haplotype GTCATTTCCTA in block B was significantly associated with reduced risk (OR = 0.5; 95% CI: 0.3-0.9). CONCLUSIONS: These results suggest that variation in VDR may be associated with breast cancer risk. IMPACT: Our findings may help guide future research needed to define the role of vitamin D in breast cancer prevention. 2012 AACR
BACKGROUND: Observational and experimental studies suggest that vitamin D may influence breast cancer etiology. Most known effects of vitamin D are mediated via the vitamin D receptor (VDR). Few polymorphisms in the VDR gene have been well studied in relation to breast cancer risk and results have been inconsistent. METHODS: We investigated VDR polymorphisms and haplotypes in relation to breast cancer risk by genotyping 26 single nucleotide polymorphisms (SNP) that (i) had known/suspected impact on VDR function, (ii) were tagging SNPs for the three VDR haplotype blocks among whites, or (iii) were previously associated with breast cancer risk. We estimated odds ratios (OR) and 95% confidence intervals (CI) in relation to breast cancer risk among 270 incident cases and 554 matched controls within the Agricultural Health Study cohort. RESULTS: In individual SNP analyses, homozygous carriers of the minor allele for rs2544038 had significantly increased breast cancer risk (OR = 1.5; 95% CI: 1.0-2.5) and homozygous carriers of the minor allele for rs11168287 had significantly decreased risk (OR = 0.6; 95% CI: 0.4-1.0). Carriers of the minor allele for rs2239181 exhibited marginally significant association with risk (OR = 1.4; 95% CI: 0.9-2.0). Haplotype analyses revealed three haplotype groups (blocks "A," "B," and "C"). Haplotype GTCATTTCCTA in block B was significantly associated with reduced risk (OR = 0.5; 95% CI: 0.3-0.9). CONCLUSIONS: These results suggest that variation in VDR may be associated with breast cancer risk. IMPACT: Our findings may help guide future research needed to define the role of vitamin D in breast cancer prevention. 2012 AACR
Authors: Yue Fang; Joyce B J van Meurs; Arnold d'Alesio; Mila Jhamai; Hongyan Zhao; Fernando Rivadeneira; Albert Hofman; Johannes P T van Leeuwen; Frédéric Jehan; Huibert A P Pols; André G Uitterlinden Journal: Am J Hum Genet Date: 2005-09-26 Impact factor: 11.025
Authors: Pia Sillanpää; Ari Hirvonen; Vesa Kataja; Matti Eskelinen; Veli-Matti Kosma; Matti Uusitupa; Harri Vainio; Katja Mitrunen Journal: Pharmacogenetics Date: 2004-04
Authors: P Gapska; R J Scott; P Serrano-Fernandez; T Huzarski; T Byrski; J Kładny; J Gronwald; B Górski; C Cybulski; J Lubinski; T Debniak Journal: Breast Cancer Res Treat Date: 2008-06-29 Impact factor: 4.872
Authors: Laura L Reimers; Katherine D Crew; Patrick T Bradshaw; Regina M Santella; Susan E Steck; Iryna Sirosh; Mary Beth Terry; Dawn L Hershman; Elizabeth Shane; Serge Cremers; Elzbieta Dworakowski; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon Journal: Cancer Causes Control Date: 2014-11-25 Impact factor: 2.506
Authors: Joy Shi; Anne Grundy; Harriet Richardson; Igor Burstyn; Johanna M Schuetz; Caroline A Lohrisch; Sandip K SenGupta; Agnes S Lai; Angela Brooks-Wilson; John J Spinelli; Kristan J Aronson Journal: Tumour Biol Date: 2015-12-02
Authors: Seo Kyung Choi; Mun Suk Park; Jun Kyu Song; Kyung Sik Yoon; Kyung Lim Yoon; Kye Shik Shim Journal: J Korean Med Sci Date: 2013-08-28 Impact factor: 2.153